Literature DB >> 16947118

Comparative proteomic studies on the pathogenesis of human ulcerative colitis.

Sen-Yung Hsieh1, Tsung-Chieh Shih, Chien-Yuh Yeh, Chun-Jung Lin, Yun-Ying Chou, Ying-Shiung Lee.   

Abstract

Ulcerative colitis (UC) is a chronic inflammatory disorder primarily affecting the colon mucosa. Its etiology and pathogenesis remain unclear. We used 2-DE and MS to identify differentially expressed proteins among the UC active, UC inactive, nonspecific colitis, and normal colon mucosa. Thirteen down-regulated and six up-regulated proteins were identified. Of the down-expressed proteins, eight (heat-shock protein 90 (HSPA9B), heat-shock protein 60 (HSPD1), H+-transporting two-sector ATPase (ATP5B), prohibitin (PHB), mitochondrial malate dehydrogenase (MDH2), voltage-dependent anion-selective channel protein 1 (VDAC1), thioredoxin peroxidase (PRDX1), and thiol-specific antioxidant (PRDX2)) were mitochondrial proteins, three (ATP5B, MDH2, triosephosphate isomerase) were involved in energy generation, three (PRDX1, PRDX2, SELENBP1) were cellular antioxidants, and six (HSPD1, HSPA9B, PRDX1, PRDX2, PHB, VDAC1) were stress-response proteins. Transmission electron microscopy revealed pathological alterations of mitochondrial ultrastructures even before the global colonocyte changes in the UC colon mucosa. PHB, an essential mitochondrial component protein, was down-expressed in the disease active as well as inactive colon mucosa from the patients of UC, indicative of an early event of mitochondrial changes during UC development. In contrast, aberrant activation of NFAT and ectopic expression of potential immunogenic proteins (tumor rejection antigen 1 and poliovirus receptor related protein 1) were found in the UC-diseased colon mucosa. Our findings suggest the implications of colonocyte mitochondrial dysfunction and perturbed mucosa immune regulation in the pathogenesis of UC and provide potential targets for the development of a new therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16947118     DOI: 10.1002/pmic.200500541

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  56 in total

1.  Comparative proteomics analysis of serum proteins in ulcerative colitis patients.

Authors:  Nan Li; Xueming Wang; Yuefan Zhang; Junshan Zhai; Tuo Zhang; Kaihua Wei
Journal:  Mol Biol Rep       Date:  2011-12-24       Impact factor: 2.316

Review 2.  The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

Authors:  Zora Djuric
Journal:  Nutr Rev       Date:  2011-12       Impact factor: 7.110

Review 3.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

Authors:  Tzu-Hao Wang; Angel Chao; Chia-Lung Tsai; Chih-Long Chang; Shun-Hua Chen; Yun-Shien Lee; Jen-Kun Chen; Yi-Jun Lin; Pi-Yueh Chang; Chin-Jung Wang; An-Shine Chao; Shuenn-Dyh Chang; Ting-Chang Chang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

Review 5.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

6.  Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation.

Authors:  Tanupriya Agrawal; Gaurav K Gupta; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2012-04-16       Impact factor: 3.362

7.  Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.

Authors:  Arianne L Theiss; Hamed Laroui; Tracy S Obertone; Indrajit Chowdhury; Winston E Thompson; Didier Merlin; Shanthi V Sitaraman
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

Review 8.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

9.  Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease.

Authors:  Moriaki Hatsugai; Manae S Kurokawa; Takefumi Kouro; Kohei Nagai; Mitsumi Arito; Kayo Masuko; Naoya Suematsu; Kazuki Okamoto; Fumio Itoh; Tomohiro Kato
Journal:  J Gastroenterol       Date:  2010-01-05       Impact factor: 7.527

10.  Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis.

Authors:  Arwa S Kathiria; Mackenzie A Butcher; Jason M Hansen; Arianne L Theiss
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-14       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.